Name | Description | Birthdate | Birthplace | ||
---|---|---|---|---|---|
Dominic Borie, MD, PhD is Chief Executive Officer at Kyverna Therapeutics. Dr. Borie is an accomplished immunologist and digestive tract and liver transplant surgeon with extensive experience in drug development. He joins Kyverna from Horizon Therapeutics where he served as Vice-President and Head, External Research and Development. | |||||
Joe Jimenez is the Co-Founder and Managing Director at Aditum Bio. | January 1, 1959 | ||||
CEO of CRISPR Therapeutics | |||||
CEO of AlloVir | |||||
Executive Chairman of the Board | |||||
Founder and CEO of Indee Labs | |||||
CEO of Pfizer & Bamboo Therapeutics, Inc., based in New York | October 21, 1961 | ||||
CEO of Atlas Venture, Magenta Therapeutics & Marqeta, based in United States & New Hampshire | |||||
Professor at Stanford University, CEO & Co-Founder of Antheia, and Co-Founder Chimera Bioengineering | January 1, 1975 | ||||
Founder of Caribou Biosciences | May 20, 1985 | ||||
former CEO of Bamboo Therapeutics, Inc. | |||||
American businessman | January 1, 1955 | ||||
American lawyer, writer and businessperson | |||||
Founder and CEO of Cell Design Labs. | |||||
Businessperson | May 23, 1959 | ||||
Investor & investor, founder of Avant Global | |||||
American chemist | October 20, 1936 | ||||
founder & CEO of Sqz Biotechnologies, based in United States | |||||
Founder of Encellin | |||||
Founder of NextGen Venture Partners | |||||
Bobby Gaspar is founder and CEO of Orchard Therapeutics | |||||
CEO of Celularity, based in Virginia | |||||
Lebanese businessman | January 23, 1965 | ||||
CEO of Marker Therapeutics | |||||
Paul Wotton is CEO at Obsidian Therapeutics. |